RECOLONY
RECOLONY
Industry:
Biotechnology
Founded:
2022-01-01
Address:
Zürich, Zurich, Switzerland
Country:
Switzerland
Website Url:
http://www.recolony.ch
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
10 K CHF
Investors List
Venture Kick
Venture Kick investment in Grant - Recolony
Official Site Inspections
http://www.recolony.ch
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.171
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147
More informations about "Recolony"
Under Construction | Recolony Therapy
We're updating Recolony's look and feel as part of our rebranding treatment. Our website is currently in recovery and will return shortly with a rejuvenated experience. Stay tuned for the healthy new reveal!See details»
Recolony - Wyss Zurich
Recolony is focusing on the development of a bacteria-based therapy for colorectal cancer that consists primarily of selected bacteria of the gut microbiota. These bacteria have an enormous impact on the immune system and are able …See details»
Recolony - Crunchbase Company Profile & Funding
Recolony is a microbial-based therapy for Colorectal cancer. A therapeutic approach using specific strains of bacteria to activate the immune system and target malignant tumors, …See details»
Recolony AG - Venturelab
May 9, 2022 · Recolony AG: At Recolony, our research of the intricate interactions between the human host and its microbiome has led to a groundbreaking discovery in the oncology field, revealing a novel, very potent …See details»
Recolony AG – Swiss Biotech
Recolony focuses on the development of cancer therapies based on microbial-derived products. These drugs have an enormous influence on our immune system, enhancing an immune …See details»
Recolony AG - top100startup.ch
Feb 29, 2024 · Recolony AG: At Recolony, our research of the intricate interactions between the human host and its microbiome has led to a groundbreaking discovery in the oncology field, …See details»
New Portfolio Start-Up: Recolony - USZ
Jul 28, 2022 · Let's welcome a new Start-Up to our portfolio: Recolony - Bacteria-based cancer therapy. Recolony is a biotech start-up to develop a bacteria-based oral therapy to treat and …See details»
UZH spin-off Recolony idolized in 20 minutes
Dec 9, 2022 · The head of the Zurich biotech start-up Recolony is researching a cancer therapy that is already causing a sensation internationally. Now her story is portrayed in 20 min. Ana …See details»
Recolony is selected for Venture Leaders Biotech - Recolony Therapy
Jul 25, 2022 · Recolony has been selected to be part of the Swiss National Startup Team 2022 and will join Venture Leaders Biotech next September in Boston!See details»
Newsroom | Recolony
Recolony ranks 10th in this annual ranking created by 100 leading investors and industry experts of the Swiss Startup scene. Recolony enters the prestigious Top100 Swiss Startups ranking as …See details»
Recolony to bring its immunotherapy into pre-clinical phase
Feb 21, 2023 · After winning the third stage of the Venture Kick competition, Recolony took home CHF 150’000. The startup will use the funds to advance its cancer immunotherapy, aiming to …See details»
Recolony AG - startup.ch
Recolony AG Cancer immunotherapy inspired by symbiotic interactions. Website: www.recolony.ch. Headquarter: Zürich ETH-Zentrum Foundation Date: September 2022See details»
Recolony AG at the Swiss Biotech Day
At Recolony, we focus our efforts in developing cancer therapies that primarily consist of selected commensal bacteria of the gut microbiota. By harnessing the potential of beneficial gut …See details»
Recolony AG - Venture Kick
May 13, 2024 · Recolony AG: At Recolony, our research of the intricate interactions between the human host and its microbiome has led to a groundbreaking discovery in the oncology field, …See details»
Venture Leader Biotech 2022 - meet Ana Montalban-Arques, co …
Jul 10, 2022 · Ana Montalban-Arques, co-founder and CEO at Recolony, a Venture Leader Biotech that develops a bacteria-based therapy for the treatment of cancer, with a particular …See details»
Recolony among the Top100 Swiss Startups - Recolony Therapy
Sep 9, 2023 · Recolony enters the prestigious Top100 Swiss Startups ranking as newcomer in its first year of existence.The TOP 100 Swiss Startup Award 2023 is made possible by presenting …See details»
Recolony wins CHF 150,000 to advance a revolutionary cancer …
Feb 21, 2023 · Recolony is developing a therapy that aims to regenerate the intestinal microbiota of cancer patients to trigger a potent anti-tumor immune response. The bacteria-based …See details»
Recolony is among the15 most promising Swiss biotech
Oct 4, 2023 · Recolony ranks 10th in this annual ranking created by 100 leading investors and industry experts of the Swiss Startup scene.See details»
Recolony – A bacteria-based cancer therapy | Gebert Rüf Stiftung
Jan 11, 2022 · Based on this finding, we are developing a life biotherapeutic product (LBP) based on lyophilized bacteria contained in gastric-resistant capsules with colonic release for oral …See details»
Press Coverage - recolony.ch
Feb 23, 2023 · Learn more about Recolony bacteria-based cancer therapy, plus never miss an event.See details»